Researcher Profile

Keywords Cloud

KRIBB Co-Working

Results 1-20 of 39 (Search time: 0.004 seconds).

No. Year Title Type
39 2024

2024Article

Pharmacokinetic interactions of niclosamide in rats: Involvement of organic anion transporters 1 and 3 and organic cation transporter 2Chemico-Biological Interactions, vol. 390, pp. 110886-110886M J Kang; Min Ju Kim; A Kim; T S Koo; Kyeong-Ryoon Lee; Y J Chae
Article
38 2024

2024Article

Proline-hinged α-helical peptides sensitize gram-positive antibiotics, expanding their physicochemical properties to be used as gram-negative antibioticsJournal of Medicinal Chemistry, vol. 67, no. 3, pp. 1825-1842Y Choi; H W Choe; M Kook; S Choo; T W Park; S Bae; H Kim; J Yang; Woo-Seong Jeong; J Yu, et al.
Article
37 2024

2024Article

Roles of breast cancer resistance protein and organic anion transporting polypeptide 2B1 in gastrointestinal toxicity induced by SN-38 under inflammatory conditionsToxicology Letters, vol. 394, pp. 57-65A Gulnaz; Kyeong-Ryoon Lee; M J Kang; J E Chang; Y J Chae
Article
36 2023

2023Article

A mechanism-based understanding of altered drug pharmacokinetics by gut microbiotaJournal of Pharmaceutical Investigation, vol. 53, pp. 73-92A Gulnaz; J E Chang; H J Maeng; K H Shin; Kyeong-Ryoon Lee; Y J Chae
Article
35 2023

2023Article

Physiologically based pharmacokinetic modelling to predict pharmacokinetics of enavogliflozin, a sodium-dependent glucose transporter 2 inhibitor, in humansPharmaceutics, vol. 15, no. 3, pp. 942-942M S Kim; Yoo-Kyung Song; J S Choi; H Y Ji; E Yang; J S Park; H S Kim; Min Joo KimIn Kyung Cho; S J Chung, et al.
Article
34 2023

2023Article

Strong inhibition of organic cation transporter 2 by flavonoids and attenuation effects on cisplatin-induced cytotoxicityChemico-Biological Interactions, vol. 379, pp. 110504-110504K H Shin; Kyeong-Ryoon Lee; M J Kang; Y J Chae
Article
33 2023

2023Article

A preliminary study of pharmacokinetics and pharmacodynamics of oral fingolimod in dogsin Vivo, vol. 37, no. 5, pp. 2128-2133T Yun; Jong Woo Jeong; Y Koo; Y Chae; D Lee; H Kim; S Kim; M P Yang; Kyeong-Ryoon Lee; B T Kang
Article
32 2022

2022Article

In vivo toxicity and pharmacokinetics of polytetrafluoroethylene microplastics in ICR micePolymers, vol. 14, no. 11, pp. 2220-2220S Lee; K K Kang; S E Sung; J H Choi; M Sung; K Y Seong; J Lee; S Kang; S Y Yang; S Lee, et al.
Article
31 2022

2022Article

Role of the efflux transporters Abcb1 and Abcg2 in the brain distribution of olaparib in miceEuropean Journal of Pharmaceutical Sciences, vol. 173, pp. 106177-106177Yoo-Kyung Song; Min Ju Kim; M S Kim; J H Lee; S J Chung; J S Song; Y J Chae; Kyeong-Ryoon Lee
Article
30 2022

2022Article

Highly specific chimeric DNA-RNA-guided genome editing with enhanced CRISPR-Cas12a systemMolecular Therapy-Nucleic Acids, vol. 28, pp. 353-362Hanseop Kim; Wi-Jae Lee; Chan Hyoung Kim; Yeounsun Oh; L W Gwon; H Lee; W Song; J K Hur; Kyung Seob LimKang Jin Jeong, et al.
Article
29 2022

2022Article

Integration of a physiologically based pharmacokinetic and pharmacodynamic model for tegoprazan and its metabolite: application for predicting food effect and intragastric pH alterationsPharmaceutics, vol. 14, no. 6, pp. 1298-1298H C Jeong; M G Kim; Z Wei; Kyeong-Ryoon Lee; J Lee; I S Song; K H Shin
Article
28 2022

2022Article

Model-based prediction of acid suppression and proposal of a new dosing regimen of fexuprazan in humansPharmaceuticals, vol. 15, no. 6, pp. 709-709M S Kim; N Lee; A Lee; Y J Chae; S J Chung; Kyeong-Ryoon Lee
Article
27 2022

2022Article

A population PK-PD model of YH4808, a novel P-CAB, and intragastric pH that incorporated negative feedback by increased intragastric pH onto the systemic exposure to YH4808CPT-Pharmacometrics & Systems Pharmacology, vol. 11, no. 9, pp. 1223-1233T K Chung; H A Lee; Kyeong-Ryoon Lee; S B Jang; K S Yu; H Lee
Article
26 2022

2022Article

Pharmacokinetics of fluconazole after oral administration to healthy beagle dogsVeterinary Dermatology, vol. 33, no. 6, pp. 509-515Y Choi; Y Koo; T Yun; Y Chae; D Lee; Jong Woo Jeong; Kyeong-Ryoon Lee; H Kim; M P Yang; B T Kang
Article
25 2022

2022Article

Findings on in vitro transporter-mediated drug interactions and their follow-up actions for labeling: analysis of drugs approved by US FDA between 2017 and 2021Pharmaceutics, vol. 14, no. 10, pp. 2078-2078Kyeong-Ryoon Lee; J E Chang; J Yoon; H Jin; Y J Chae
Article
24 2022

2022Article

Bioanalysis of alpelisib using liquid chromatography-tandem mass spectrometry and application to pharmacokinetic studyJournal of Analytical Science and Technology, vol. 13, pp. 31-31Seop Lee; M S Kim; Jong Woo Jeong; J W Chae; T S Koo; H J Maeng; S J Chung; Kyeong-Ryoon Lee; Y J Chae
Article
23 2022

2022Article

Sensitive and valid assay for reliable evaluation of drug interactions mediated by human organic anion transporter 1 and 3 using 5-carboxyfluoresceinAnalytical Sciences, vol. 38, no. 10, pp. 1347-1357Kyeong-Ryoon Lee; J E Chang; Y J Chae
Article
22 2022

2022Article

Regulation of drug transporters by microRNA and implications in disease treatmentJournal of Pharmaceutical Investigation, vol. 52, pp. 23-47Y J Chae; J E Chang; M K Lee; J Lim; K H Shin; Kyeong-Ryoon Lee
Article
21 2021

2021Article

Development of physiologically based pharmacokinetic model for orally administered fexuprazan in humansPharmaceutics, vol. 13, no. 6, pp. 813-813Y S Jeong; M S Kim; N Lee; A Lee; Y J Chae; S J Chung; Kyeong-Ryoon Lee
Article
20 2021

2021Article

Interplay among conformation, intramolecular hydrogen bonds, and chameleonicity in the membrane permeability and cyclophilin A binding of Mmacrocyclic peptide cyclosporin O derivativesJournal of Medicinal Chemistry, vol. 64, no. 12, pp. 8272-8286D Lee; S Lee; J Choi; Y K Song; Min Ju Kim; D S Shin; M A Bae; Y C Kim; C J Park; Kyeong-Ryoon Lee, et al.
Article
1 2